Your browser doesn't support javascript.
loading
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Hecht, Anna; Meyer, Julia A; Jann, Johann-Christoph; Sockel, Katja; Giagounidis, Aristoteles; Götze, Katharina S; Letsch, Anne; Haase, Detlef; Schlenk, Richard F; Haferlach, Torsten; Schafhausen, Philippe; Bug, Gesine; Lübbert, Michael; Thol, Felicitas; Büsche, Guntram; Schuler, Esther; Nowak, Verena; Obländer, Julia; Fey, Stephanie; Müller, Nadine; Metzgeroth, Georgia; Hofmann, Wolf-Karsten; Germing, Ulrich; Nolte, Florian; Reinwald, Mark; Nowak, Daniel.
Afiliação
  • Hecht A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany. anna.hecht@medma.uni-heidelberg.de.
  • Meyer JA; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Jann JC; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Sockel K; Department of Hematology, University Hospital Dresden, Dresden, Germany.
  • Giagounidis A; Department of Hematology, Oncology and Palliative Care, Marien Hospital Duesseldorf, Duesseldorf, Germany.
  • Götze KS; Department of Internal Medicine, Technical University of Munich, Munich, Germany.
  • Letsch A; Department of Hematology and Oncology, Charité, Benjamin Franklin University, Berlin, Germany.
  • Haase D; Clinics of Hematology and Medical Oncology, University Medicine Goettingen, Goettingen, Germany.
  • Schlenk RF; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Schafhausen P; Department of Oncology, Hematology, BMT with section Pneumology, Hubertus Wald Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bug G; Department of Internal Medicine, University Hospital Frankfurt, Frankfurt, Germany.
  • Lübbert M; Internal Medicine, University Hospital Freiburg, Freiburg, Germany.
  • Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Büsche G; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Schuler E; Department for Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich-Heine-University, Duesseldorf, Germany.
  • Nowak V; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Obländer J; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Fey S; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Müller N; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Metzgeroth G; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Germing U; Department for Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich-Heine-University, Duesseldorf, Germany.
  • Nolte F; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Reinwald M; Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.
  • Nowak D; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
Ann Hematol ; 100(6): 1463-1471, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33903952

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Metilação de DNA / Lenalidomida / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Metilação de DNA / Lenalidomida / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article